STIM — Neuronetics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1227636 ·
Last close
$1.21
Market Cap
$84.20M
52W High
$2.47
52W Low
$1.12
ADV30
2,327,380
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 34,454,000 | 16,154,000 | -8,995,000 | -10,790,000 | 125,440,000 | 13,214,000 | 108,380,000 |
| Dec 2025 | 41,777,000 | 21,704,000 | -5,043,000 | -7,158,000 | 141,551,000 | 28,134,000 | 115,311,000 |
| Sep 2025 | 37,297,000 | 17,108,000 | -7,321,000 | -9,045,000 | 145,465,000 | 27,971,000 | 114,105,000 |
| Jun 2025 | 38,108,000 | 17,758,000 | -8,058,000 | -10,120,000 | 134,650,000 | 10,969,000 | 103,143,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,374,000
Investing CF
$-801,000
Financing CF
$35,850,000
CapEx
$-801,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.59
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-458,787,000
Inventory
$4,327,000
Receivables
$16,893,000
ST Investments
$225,000
EBIT TTM
$-31,520,000
Pretax Income TTM
$-39,120,000
Interest Exp TTM
$7,600,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$151,636,000
EBITDA
$-25,778,000
Free Cash Flow
$-4,582,000
Enterprise Value
$159,474,400
Total Cash
$13,214,000
Total Debt
$85,388,000
Shares Out
69,587,840
Trailing EPS
$-0.54
Book Value
$0.19
ROE
-131.6%
ROA
-13.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 149,157,000 | -31,436,000 | -38,998,000 | 141,551,000 | 115,311,000 | — | -20,374,000 |
| Dec 2024 | 74,890,000 | -34,563,000 | -43,708,000 | 140,903,000 | 109,104,000 | — | -30,997,000 |
| Dec 2023 | 71,348,000 | -30,554,000 | -30,189,000 | 115,831,000 | 81,641,000 | — | -32,038,000 |
| Dec 2022 | 65,206,000 | -35,111,000 | -37,159,000 | 116,884,000 | 59,824,000 | — | -30,739,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.34
Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $1.00 · spot: $1.21 · call volume: 213 · put volume: 12
Expected Move to 2026-08-21:
±$0.99
(81.82%) —
implied range
$0.22 –
$2.20
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SKIN | SkinHealth Systems Inc. | $84.23M | $0.65 | — |
| EBRCZ | EBR Systems, Inc. | $84.30M | $0.19 | — |
| NRXS | Neuraxis, INC | $83.10M | $6.71 | — |
| PYPD | PolyPid Ltd. | $87.43M | $4.56 | — |
| SNWV | SANUWAVE Health, Inc. | $78.16M | $9.09 | — |
News headlines (Yahoo Finance, 1h cache)
Neuronetics Appoints Robert Greene as Senior Vice President Sales
2026-06-02 20:30 · Yahoo
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
2026-06-02 12:32 · Yahoo
Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
2026-06-01 11:00 · Yahoo
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
2026-05-14 12:32 · Yahoo
Neuronetics Q1 Earnings Call Highlights
2026-05-05 21:07 · Yahoo
Neuronetics, Inc. Q1 2026 Earnings Call Summary
2026-05-05 20:55 · Yahoo
Neuronetics (STIM) Q1 2026 Earnings Transcript
2026-05-05 20:20 · Yahoo
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 13:15 · Yahoo
Neuronetics Reports First Quarter 2026 Financial and Operating Results
2026-05-05 11:50 · Yahoo
How The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price Target
2026-05-02 14:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.